All lobbying filings

The Russell Group, Inc.

The Russell Group, Inc. filed a Q1 termination report for Novozymes North America Inc. on April 8, 2026, reporting $50,000 in lobbying income.

Lobbying for Novozymes North America Inc. · Biotech company

As filed: THE RUSSELL GROUP, INC. for NOVOZYMES NORTH AMERICA INC.

All filings by The Russell Group, Inc. · Everything Novozymes North America Inc. has reported

Filing · LD-2 quarterly report Q1 termination

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 8, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

North Carolina

Representation ended

Mar 31, 2026

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Agriculture

Issues pertaining to biosolutions; issues related to gene editing and biotech regulation; issues related to trade; issues pertaining to biological solutions; issues related to biofuels; issues pertaining to nutrition policy; and issues pertaining to the Farm Bill.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.